It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Staphylococcus aureus is a human commensal and also an opportunist pathogen causing life threatening infections. During S. aureus disease, the abscesses that characterise infection can be clonal, whereby a large bacterial population is founded by a single or few organisms. Our previous work has shown that macrophages are responsible for restricting bacterial growth such that a population bottleneck occurs and clonality can emerge. A subset of phagocytes fail to control S. aureus resulting in bacterial division, escape and founding of microabscesses that can seed other host niches. Here we investigate the basis for clonal microabscess formation, using in vitro and in silico models of S. aureus macrophage infection. Macrophages that fail to control S. aureus are characterised by formation of intracellular bacterial masses, followed by cell lysis. High-resolution microscopy reveals that most macrophages had internalised only a single S. aureus, providing a conceptual framework for clonal microabscess generation, which was supported by a stochastic individual-based, mathematical model. Once a threshold of masses was reached, increasing the number of infecting bacteria did not result in greater mass numbers, despite enhanced phagocytosis. This suggests a finite number of permissive, phagocyte niches determined by macrophage associated factors. Increased understanding of the parameters of infection dynamics provides avenues for development of rational control measures.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 University of Sheffield, School of Biosciences, Sheffield, UK (GRID:grid.11835.3e) (ISNI:0000 0004 1936 9262); University of Sheffield, Florey Institute, Sheffield, UK (GRID:grid.11835.3e) (ISNI:0000 0004 1936 9262)
2 University of Sheffield, School of Biosciences, Sheffield, UK (GRID:grid.11835.3e) (ISNI:0000 0004 1936 9262); University of Sheffield, Florey Institute, Sheffield, UK (GRID:grid.11835.3e) (ISNI:0000 0004 1936 9262); University of Sheffield, The Bateson Centre, Sheffield, UK (GRID:grid.11835.3e) (ISNI:0000 0004 1936 9262)
3 University of Sheffield, School of Mathematics & Statistics, Sheffield, UK (GRID:grid.11835.3e) (ISNI:0000 0004 1936 9262)
4 University of Sheffield, Florey Institute, Sheffield, UK (GRID:grid.11835.3e) (ISNI:0000 0004 1936 9262); University of Sheffield, The Bateson Centre, Sheffield, UK (GRID:grid.11835.3e) (ISNI:0000 0004 1936 9262); University of Sheffield, Department of Infection, Immunity and Cardiovascular Disease, Medical School, Sheffield, UK (GRID:grid.11835.3e) (ISNI:0000 0004 1936 9262)